Literature DB >> 31563869

Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.

Hong-Jaan Wang1, Leslie Z Benet2.   

Abstract

This study re-examined the hepatic extraction for diazepam, the only drug for which isolated perfused rat liver (IPRL) studies have been reported not to be consistent with the well stirred model of organ elimination when only entering and exiting liver concentration measurements are available. First, the time dependency of diazepam equilibrium fraction unbound measurements from 4 to 24 hours was tested, reporting the continuing increases with time. The results showed that the time dependency of equilibrium protein-binding measurements for very highly bound drugs may be an issue that is not readily overcome. When examining C out/C in (F obs) measurements for diazepam when no protein is added to the incubation media, IPRL outcomes were consistent with previous reports showing marked underpredictability of in vivo clearance from in vitro measures of elimination in the absence of protein for very highly bound drugs, which is markedly diminished in the presence of albumin. F obs for diazepam at additional low concentrations of protein that would allow discrimination of the models of hepatic elimination produced results that were not consistent with the dispersion and parallel-tube models. Therefore, although the outcomes of this study were similar to those reported by Rowland and co-workers, when no protein is added to the perfusion media, these IPRL results for diazepam cannot be reasonably interpreted as proving that hepatic organ elimination is model-independent or as supporting the dispersion and parallel-tube models of organ elimination. SIGNIFICANCE STATEMENT: The only drug experiments for which isolated perfusion rat liver studies do not support hepatic clearance being best described by the well stirred model have been carried out with diazepam at zero protein concentration. This study repeated those studies, confirming the previous results at zero protein concentration, but the addition of low protein-binding conditions capable of differentiating the various models of hepatic elimination are more consistent with the well stirred model of hepatic elimination. These experimental studies do not support the preference for alternate models of hepatic elimination or the proposal that hepatic organ clearance is model-independent.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31563869      PMCID: PMC7042717          DOI: 10.1124/dmd.119.088872

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  19 in total

Review 1.  An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.

Authors:  C M Bowman; L Z Benet
Journal:  Eur J Pharm Sci       Date:  2018-08-08       Impact factor: 4.384

2.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

3.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

4.  Commentary on "The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio".

Authors:  Malcolm Rowland; K Sandy Pang
Journal:  Clin Pharmacol Ther       Date:  2017-11-14       Impact factor: 6.875

Review 5.  The potential protein-mediated hepatic uptake: discussion on the molecular interactions between albumin and the hepatocyte cell surface and their implications for the in vitro-to-in vivo extrapolations of hepatic clearance of drugs.

Authors:  Michel Bteich; Patrick Poulin; Sami Haddad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-07-18       Impact factor: 4.481

6.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

7.  Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918.

Authors:  Chi-Yuan Wu; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2003-11       Impact factor: 3.922

8.  Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay.

Authors:  Yvonne Y Lau; Chi-Yuan Wu; Hideaki Okochi; Leslie Z Benet
Journal:  J Pharmacol Exp Ther       Date:  2003-11-21       Impact factor: 4.030

9.  Sensitive UPLC-MS-MS assay for 21 benzodiazepine drugs and metabolites, zolpidem and zopiclone in serum or plasma.

Authors:  Stephanie J Marin; Mark Roberts; Michelle Wood; Gwendolyn A McMillin
Journal:  J Anal Toxicol       Date:  2012-07-23       Impact factor: 3.367

10.  Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.

Authors:  Nigel J Waters; Rachel Jones; Gareth Williams; Bindi Sohal
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

View more
  1 in total

1.  Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?

Authors:  Jasleen K Sodhi; Hong-Jaan Wang; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2020-04-17       Impact factor: 3.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.